Miehlke Stephan, Aust Daniela, Mihály Emese, Armerding Peter, Böhm Günther, Bonderup Ole, . . . et al. (2018). Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis.
Chicago Style (17th ed.) CitationMiehlke Stephan, et al. Efficacy and Safety of Budesonide, Vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis. 2018.
MLA idézésMiehlke Stephan, et al. Efficacy and Safety of Budesonide, Vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis. 2018.
Figyelem: ezek az hivatkozások nem 100%-ban pontosak..